Melanoma genetics/genomics

110.2K

views

57

authors

16

articles

Melanoma genetics/genomics

110.2K

views

57

authors

16

articles

Editorial

17 December 2013

Melanoma Genetics/Genomics

Michael R. Eccles

4,424 views

1 citations

Editors

1

University of Otago

Impact

About

Melanoma is a complex disease driven both by genetic and environmental risk factors, and requires multiple genetic mutations in the evolution from benign nevus into malignant melanoma (MM). Genetic studies of familial and sporadic melanoma have revealed surprising insights into the molecular pathogenesis of this deadly cancer. Collectively, the molecular data show there are four signature pathways involved in melanomagenesis: activation of the RAS?RAF?MEK?ERK and PI3K?AKT pathways and inactivation of the INK4a?RB and ARF?P53 pathways (Chin, 2003). Acting in a coordinated manner, these pathways provide melanocytes the requisite acquired abilities needed to develop into cancer cells: growth-factor independence, insensitivity to anti-growth signals, apoptosis evasion, limitless replicative potential, sustained angiogenesis and tissue invasion and metastasis. Insights into the relative roles and interactions between these pathways have been provided through multiple different experimental approaches and systems, which span from human GWAS and familial studies and/or tumour sequencing to zebrafish and mouse transgenic and knockout models, retroposon mutagenesis studies, cell culture systems, developmental biology, and gene expression studies to name a few.

Melanoma is a complex disease driven both by genetic and environmental risk factors, and requires multiple genetic mutations in the evolution from benign nevus into malignant melanoma (MM). Genetic studies of familial and sporadic melanoma have revealed surprising insights into the molecular pathogenesis of this deadly cancer. Collectively, the molecular data show there are four signature pathways involved in melanomagenesis: activation of the RAS?RAF?MEK?ERK and PI3K?AKT pathways and inactivation of the INK4a?RB and ARF?P53 pathways (Chin, 2003). Acting in a coordinated manner, these pathways provide melanocytes the requisite acquired abilities needed to develop into cancer cells: growth-factor independence, insensitivity to anti-growth signals, apoptosis evasion, limitless replicative potential, sustained angiogenesis and tissue invasion and metastasis. Insights into the relative roles and interactions between these pathways have been provided through multiple different experimental approaches and systems, which span from human GWAS and familial studies and/or tumour sequencing to zebrafish and mouse transgenic and knockout models, retroposon mutagenesis studies, cell culture systems, developmental biology, and gene expression studies to name a few.

Download ebook

Share

Editors

University of Otago

Impact

110,242 Total views

84,457 Article views

23,237 Article downloads

2,548 Topic views

Published In

Journal Thumbnail

Frontiers in Oncology

Cancer Genetics

Journal Thumbnail

Frontiers in Genetics

Cancer Genetics

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic